Drugs for rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D015507:Drugs, Investigational; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D050607:Organogold Compounds; D010396:Penicillamine / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D015507:Drugs, Investigational; D050607:Organogold Compounds; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D010396:Penicillamine; D001379:Azathioprine; D001241:Aspirin; D008727:Methotrexate